CHI Advisors LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHI Advisors LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2021$611,000
-38.6%
15,000
-65.0%
0.12%
-56.4%
Q4 2020$995,000
+9.6%
42,800
+64.6%
0.28%
-13.3%
Q3 2020$908,000
+10.6%
26,000
+100.0%
0.32%
+0.9%
Q2 2020$821,000
+2.0%
13,000
-17.5%
0.32%
-83.1%
Q1 2020$805,000
-49.4%
15,750
-21.2%
1.90%
+58.2%
Q4 2019$1,590,000
+17.0%
20,000
-28.6%
1.20%
-9.4%
Q3 2019$1,359,00028,0001.32%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders